Sharepoint Solutions
PRODUCTS
-
Finding a partner with integrated services is crucial for accelerating timelines and accessing solutions with comprehensive expertise, all while removing risk from the drug product lifecycle.
-
The DecFill LM-200 and DecFill LM-560 are compact, fully automatic labeling machines designed for the automated labeling of vials, bottles, syringes, ampules, cartridges, and other containers with self-adhesive labels.
-
Guide operators through dynamic workflows from equipment startup to maintenance.
-
Seamlessly integrated with Curebase’s ePRO/eCOA suite, our EDC enables hybrid and site-based studies that users will love and that streamline all of your data collection into a single, modern experience.
-
We have centralized RNA, cell, protein, and vector engineering to improve productivity and scalability and to ensure external partners and internal programs have access to the necessary tools to build novel therapies.
WHITE PAPERS AND CASE STUDIES
-
Navigating The Translation To Clinic: Future-Proof Your Plasmid Products
Future-proofing products with strategies that reduce risk and timelines for later stages can be resource-intensive but add significant value. Explore the challenges encountered progressing from development to clinic.
-
Alzheimer's Study Involving Home Infusions Exceeds Expectations
Gain insight from this Phase 3 global clinical trial focused on pre-clinical Alzheimer’s Disease where adult patients received one-hour intravenous infusions every month for 4.5 years.
-
Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials
This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.
-
Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech
This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.
-
Case Study: Recruiting Pediatric Ultra-Rare Disease Patients
Explore how Rezolute was able to overcome challenges while recruiting pediatric patients for a Congenital Hyperinsulinism (HI) clinical trial using a streamlined, single-source tool.
-
Project Orbis Drug Registration 2025
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.
-
eSource Purpose Is Not Just To Complete The EDC
Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
Innovative ASD Technology Improves Abandoned Cancer Medication
Review this case to learn how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.
-
Patient-Focused Data Capture For Cancer Research
In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.
-
Fortrea Optimizes Site Matching On Retina Clinical Trials
Faced with challenges in engaging clinical trial sites within the retina research landscape, Fortrea sought a partnership that leverages RWD to streamline site feasibility assessments.
-
Improving Patient Health and Safety: Quality and Analytical Scientist
Explore how an analytical scientist enhanced quality and compliance for a pharmaceutical company by managing complex analytical testing and vendor interactions.
-
Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments
During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.
NEWS
-
NEW Group Itinerary Builder Developed By UrVenue + Club Med To Debut At HITEC6/24/2024
A new tool developed by UrVenue and Club Med will be unveiled this week at HITEC, held now through June 27 at the Charlotte (N.C.) Convention Center
-
EPA Announces $89M Loan To Enhance Wastewater Management In King County12/18/2024
Today, the U.S. Environmental Protection Agency announced an $89M loan to King County, Washington, to help upgrade several wastewater treatment systems. Provided by the EPA’s Water Infrastructure Finance and Innovation Act (WIFIA) loan program, this funding will support projects that improve the reliability of reclaimed water available for use and enhance the system’s resiliency to future seismic events.
-
Biden-Harris Administration Announces $3.6B For Water Infrastructure Through Investing in America Agenda10/23/2024
the U.S. Environmental Protection Agency announced $3.6B in new funding under the Biden-Harris Administration’s Bipartisan Infrastructure Law to upgrade water infrastructure and keep communities safe.
-
EPA Announces $194M To King County To Improve Wastewater Infrastructure Resiliency, Protect Puget Sound3/28/2024
Today, at an event at the West Point Treatment Plant, the U.S. Environmental Protection Agency Acting Assistant Administrator for Water Bruno Pigott announced a $194M Water Infrastructure Finance and Innovation Act loan to King County in Washington.
-
Global Hydrogen Market: Uniper And thyssenkrupp Uhde Sign Framework Agreement On The Use Of Ammonia Cracking Technology11/26/2025
Uniper and thyssenkrupp Uhde have signed a framework agreement that lays the foundation for the construction of commercial ammonia cracking plants.